Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.94 CHF | -0.68% | -2.11% | -0.70% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 18 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.70% | 203B | |
+27.97% | 672B | |
+23.78% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.81% | 211B | |
-10.14% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : Morgan Stanley Lifts Price Target on Novartis, Maintains Overweight/In-Line Recommendation